Author pages are created from data sourced from our academic publisher partnerships and public sources.
Topical axitinib is a potent inhibitor of corneal neovascularization
- Mariola Lledó Riquelme, E. Campos-Mollo, L. Fernández-Sánchez
- Clinical & experimental ophthalmology
- 1 December 2018
This study evaluated the effects of topically applied axitinib, a tyrosine kinase inhibitor, in an experimental model of corneal neovascularization (CNV).